Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0RECPU
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
ABL-202
|
|||||
| Synonyms |
ABL 202; ABL202
Click to Show/Hide
|
|||||
| Organization |
ABL Bio, Inc.; CStone Pharmaceuticals Co. Ltd.
|
|||||
| Drug Status |
Phase 1
|
|||||
| Indication |
In total 2 Indication(s)
B-cell lymphoma [ICD11:2A86]
Phase 1
Breast cancer [ICD11:2C60-2C65]
Phase 1
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.